nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—Propranolol—migraine	0.267	1	CrCtD
Duloxetine—HTR2C—migraine	0.0661	0.406	CbGaD
Duloxetine—SLC6A4—migraine	0.0547	0.336	CbGaD
Duloxetine—endogenous depression—Amitriptyline—migraine	0.0541	0.255	CpDpCtD
Duloxetine—Naphazoline—Propranolol—migraine	0.0518	0.367	CrCrCtD
Duloxetine—bipolar disorder—Topiramate—migraine	0.0482	0.227	CpDpCtD
Duloxetine—endogenous depression—Valproic Acid—migraine	0.046	0.216	CpDpCtD
Duloxetine—HTR2A—migraine	0.0421	0.258	CbGaD
Duloxetine—Cinacalcet—Propranolol—migraine	0.0401	0.284	CrCrCtD
Duloxetine—bipolar disorder—Valproic Acid—migraine	0.0366	0.172	CpDpCtD
Duloxetine—Demexiptiline—Propranolol—migraine	0.0331	0.234	CrCrCtD
Duloxetine—bipolar disorder—Gabapentin—migraine	0.0277	0.13	CpDpCtD
Duloxetine—HTR6—Amitriptyline—migraine	0.0223	0.182	CbGbCtD
Duloxetine—Atomoxetine—Propranolol—migraine	0.0163	0.115	CrCrCtD
Duloxetine—SLC6A4—Amitriptyline—migraine	0.0155	0.127	CbGbCtD
Duloxetine—SLC6A2—Amitriptyline—migraine	0.0129	0.106	CbGbCtD
Duloxetine—HTR2C—Amitriptyline—migraine	0.0129	0.106	CbGbCtD
Duloxetine—SLC6A4—Verapamil—migraine	0.0123	0.1	CbGbCtD
Duloxetine—HTR2A—Amitriptyline—migraine	0.0117	0.0955	CbGbCtD
Duloxetine—CYP1A2—Propranolol—migraine	0.00545	0.0446	CbGbCtD
Duloxetine—CYP2D6—Timolol—migraine	0.00504	0.0412	CbGbCtD
Duloxetine—CYP1A2—Amitriptyline—migraine	0.00471	0.0385	CbGbCtD
Duloxetine—CYP2D6—Propranolol—migraine	0.00449	0.0367	CbGbCtD
Duloxetine—CYP1A2—Valproic Acid—migraine	0.00429	0.0351	CbGbCtD
Duloxetine—CYP2D6—Amitriptyline—migraine	0.00388	0.0318	CbGbCtD
Duloxetine—CYP1A2—Verapamil—migraine	0.00374	0.0306	CbGbCtD
Duloxetine—CYP2D6—Verapamil—migraine	0.00308	0.0252	CbGbCtD
Duloxetine—HTR2A—trigeminal nucleus—migraine	0.00219	0.145	CbGeAlD
Duloxetine—SLC6A2—locus ceruleus—migraine	0.00117	0.0775	CbGeAlD
Duloxetine—NPY1R—nerve—migraine	0.00103	0.0682	CbGeAlD
Duloxetine—SLC6A2—sympathetic nervous system—migraine	0.000923	0.0612	CbGeAlD
Duloxetine—HTR2A—locus ceruleus—migraine	0.000702	0.0466	CbGeAlD
Duloxetine—SLC6A2—autonomic nervous system—migraine	0.00062	0.0412	CbGeAlD
Duloxetine—HTR2A—trigeminal nerve—migraine	0.000574	0.0381	CbGeAlD
Duloxetine—HTR2A—sympathetic nervous system—migraine	0.000555	0.0368	CbGeAlD
Duloxetine—SLC6A3—nerve—migraine	0.000433	0.0287	CbGeAlD
Duloxetine—HTR2A—cranial nerve—migraine	0.000409	0.0272	CbGeAlD
Duloxetine—HTR2A—pons—migraine	0.000404	0.0268	CbGeAlD
Duloxetine—HTR2A—autonomic nervous system—migraine	0.000373	0.0247	CbGeAlD
Duloxetine—SLC6A2—nerve—migraine	0.000349	0.0232	CbGeAlD
Duloxetine—HTR2A—pineal body—migraine	0.000289	0.0192	CbGeAlD
Duloxetine—HTR2A—peripheral nervous system—migraine	0.000269	0.0179	CbGeAlD
Duloxetine—NPY1R—head—migraine	0.000244	0.0162	CbGeAlD
Duloxetine—NPY1R—nervous system—migraine	0.000231	0.0153	CbGeAlD
Duloxetine—NPY1R—central nervous system—migraine	0.000223	0.0148	CbGeAlD
Duloxetine—HTR2A—nerve—migraine	0.00021	0.0139	CbGeAlD
Duloxetine—SLC6A3—brainstem—migraine	0.000186	0.0123	CbGeAlD
Duloxetine—HTR2C—brainstem—migraine	0.00018	0.0119	CbGeAlD
Duloxetine—NPY1R—brain—migraine	0.000177	0.0117	CbGeAlD
Duloxetine—HTR6—head—migraine	0.000172	0.0114	CbGeAlD
Duloxetine—SLC6A4—brainstem—migraine	0.00017	0.0113	CbGeAlD
Duloxetine—Atomoxetine—HTR1D—migraine	0.000169	0.152	CrCbGaD
Duloxetine—HTR2A—blood vessel—migraine	0.000165	0.0109	CbGeAlD
Duloxetine—HTR6—nervous system—migraine	0.000163	0.0108	CbGeAlD
Duloxetine—HTR6—central nervous system—migraine	0.000157	0.0104	CbGeAlD
Duloxetine—Protriptyline—SLC6A4—migraine	0.000154	0.139	CrCbGaD
Duloxetine—SLC6A2—brainstem—migraine	0.00015	0.00994	CbGeAlD
Duloxetine—Fluoxetine—HTR2C—migraine	0.000127	0.115	CrCbGaD
Duloxetine—HTR6—brain—migraine	0.000124	0.00825	CbGeAlD
Duloxetine—HTR2A—neck—migraine	0.000118	0.00782	CbGeAlD
Duloxetine—Fluoxetine—SLC6A4—migraine	0.000105	0.095	CrCbGaD
Duloxetine—SLC6A3—head—migraine	0.000103	0.00681	CbGeAlD
Duloxetine—Atomoxetine—HTR1B—migraine	0.0001	0.0904	CrCbGaD
Duloxetine—HTR2C—head—migraine	9.92e-05	0.00658	CbGeAlD
Duloxetine—SLC6A3—nervous system—migraine	9.73e-05	0.00646	CbGeAlD
Duloxetine—Propranolol—HTR1B—migraine	9.5e-05	0.0858	CrCbGaD
Duloxetine—HTR2C—nervous system—migraine	9.4e-05	0.00624	CbGeAlD
Duloxetine—SLC6A4—head—migraine	9.4e-05	0.00624	CbGeAlD
Duloxetine—SLC6A3—central nervous system—migraine	9.37e-05	0.00622	CbGeAlD
Duloxetine—SLC6A3—cerebellum—migraine	9.16e-05	0.00607	CbGeAlD
Duloxetine—HTR2C—central nervous system—migraine	9.05e-05	0.00601	CbGeAlD
Duloxetine—HTR2A—brainstem—migraine	9e-05	0.00597	CbGeAlD
Duloxetine—SLC6A4—nervous system—migraine	8.92e-05	0.00592	CbGeAlD
Duloxetine—SLC6A4—central nervous system—migraine	8.58e-05	0.0057	CbGeAlD
Duloxetine—SLC6A2—head—migraine	8.28e-05	0.00549	CbGeAlD
Duloxetine—CYP2D6—brainstem—migraine	8.2e-05	0.00544	CbGeAlD
Duloxetine—Atomoxetine—HTR2C—migraine	8.15e-05	0.0737	CrCbGaD
Duloxetine—Fluoxetine—HTR2A—migraine	8.08e-05	0.073	CrCbGaD
Duloxetine—SLC6A2—nervous system—migraine	7.85e-05	0.00521	CbGeAlD
Duloxetine—SLC6A2—central nervous system—migraine	7.56e-05	0.00501	CbGeAlD
Duloxetine—Propranolol—HTR1A—migraine	7.52e-05	0.0679	CrCbGaD
Duloxetine—SLC6A3—brain—migraine	7.44e-05	0.00493	CbGeAlD
Duloxetine—HTR2A—cardiovascular system—migraine	7.35e-05	0.00488	CbGeAlD
Duloxetine—HTR2C—brain—migraine	7.19e-05	0.00477	CbGeAlD
Duloxetine—SLC6A4—brain—migraine	6.81e-05	0.00452	CbGeAlD
Duloxetine—Atomoxetine—SLC6A4—migraine	6.76e-05	0.061	CrCbGaD
Duloxetine—SLC6A2—brain—migraine	6e-05	0.00398	CbGeAlD
Duloxetine—Atomoxetine—HTR2A—migraine	5.19e-05	0.0469	CrCbGaD
Duloxetine—HTR2A—head—migraine	4.98e-05	0.0033	CbGeAlD
Duloxetine—HTR2A—nervous system—migraine	4.72e-05	0.00313	CbGeAlD
Duloxetine—HTR2A—central nervous system—migraine	4.54e-05	0.00301	CbGeAlD
Duloxetine—CYP2D6—head—migraine	4.53e-05	0.00301	CbGeAlD
Duloxetine—HTR2A—cerebellum—migraine	4.44e-05	0.00295	CbGeAlD
Duloxetine—CYP2D6—nervous system—migraine	4.3e-05	0.00285	CbGeAlD
Duloxetine—CYP2D6—central nervous system—migraine	4.14e-05	0.00275	CbGeAlD
Duloxetine—CYP2D6—cerebellum—migraine	4.04e-05	0.00268	CbGeAlD
Duloxetine—HTR2A—brain—migraine	3.61e-05	0.00239	CbGeAlD
Duloxetine—CYP2D6—brain—migraine	3.29e-05	0.00218	CbGeAlD
Duloxetine—HTR2C—G alpha (q) signalling events—NPS—migraine	3.03e-05	0.0011	CbGpPWpGaD
Duloxetine—HTR2C—G alpha (q) signalling events—TAC1—migraine	3.03e-05	0.0011	CbGpPWpGaD
Duloxetine—SLC6A3—NRF2 pathway—TGFBR2—migraine	3e-05	0.00109	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—SLC6A4—migraine	2.98e-05	0.00109	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—HTR1D—migraine	2.97e-05	0.00108	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—HTR1A—migraine	2.93e-05	0.00107	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—CALCA—migraine	2.92e-05	0.00106	CbGpPWpGaD
Duloxetine—HTR2C—G alpha (q) signalling events—EDNRA—migraine	2.89e-05	0.00105	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—TAC1—migraine	2.88e-05	0.00105	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—NPS—migraine	2.88e-05	0.00105	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	2.87e-05	0.00105	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—HTR2C—migraine	2.83e-05	0.00103	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	2.82e-05	0.00103	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—RAMP1—migraine	2.81e-05	0.00102	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CALCRL—migraine	2.81e-05	0.00102	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—HTR3A—migraine	2.77e-05	0.00101	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	2.76e-05	0.00101	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—HTR2B—migraine	2.76e-05	0.001	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—EDNRA—migraine	2.75e-05	0.001	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—HTR7—migraine	2.73e-05	0.000994	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—HTR7—migraine	2.73e-05	0.000994	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	2.72e-05	0.000992	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	2.72e-05	0.000992	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	2.71e-05	0.000986	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	2.71e-05	0.000986	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	2.67e-05	0.000972	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—HTR1D—migraine	2.66e-05	0.000968	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CALCA—migraine	2.65e-05	0.000965	CbGpPWpGaD
Duloxetine—Mental disorder—Gabapentin—migraine	2.64e-05	0.000521	CcSEcCtD
Duloxetine—Dry mouth—Valproic Acid—migraine	2.63e-05	0.00052	CcSEcCtD
Duloxetine—HTR2A—G alpha (q) signalling events—NPS—migraine	2.63e-05	0.000958	CbGpPWpGaD
Duloxetine—HTR2A—G alpha (q) signalling events—TAC1—migraine	2.63e-05	0.000958	CbGpPWpGaD
Duloxetine—Erythema—Gabapentin—migraine	2.62e-05	0.000518	CcSEcCtD
Duloxetine—Malnutrition—Gabapentin—migraine	2.62e-05	0.000518	CcSEcCtD
Duloxetine—Dizziness—Propranolol—migraine	2.62e-05	0.000517	CcSEcCtD
Duloxetine—Asthenia—Verapamil—migraine	2.61e-05	0.000516	CcSEcCtD
Duloxetine—Confusional state—Valproic Acid—migraine	2.6e-05	0.000514	CcSEcCtD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	2.6e-05	0.000946	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	2.58e-05	0.000941	CbGpPWpGaD
Duloxetine—Flatulence—Gabapentin—migraine	2.58e-05	0.00051	CcSEcCtD
Duloxetine—Oedema—Valproic Acid—migraine	2.58e-05	0.00051	CcSEcCtD
Duloxetine—Anaphylactic shock—Valproic Acid—migraine	2.58e-05	0.00051	CcSEcCtD
Duloxetine—HTR2A—G alpha (q) signalling events—HTR2C—migraine	2.58e-05	0.000939	CbGpPWpGaD
Duloxetine—Pruritus—Verapamil—migraine	2.57e-05	0.000509	CcSEcCtD
Duloxetine—Tension—Gabapentin—migraine	2.57e-05	0.000508	CcSEcCtD
Duloxetine—Angioedema—Timolol—migraine	2.57e-05	0.000508	CcSEcCtD
Duloxetine—Dysgeusia—Gabapentin—migraine	2.57e-05	0.000507	CcSEcCtD
Duloxetine—Infection—Valproic Acid—migraine	2.56e-05	0.000506	CcSEcCtD
Duloxetine—HTR6—Signaling by GPCR—CALCRL—migraine	2.55e-05	0.000929	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—RAMP1—migraine	2.55e-05	0.000929	CbGpPWpGaD
Duloxetine—Haemoglobin—Topiramate—migraine	2.55e-05	0.000503	CcSEcCtD
Duloxetine—Nervousness—Gabapentin—migraine	2.55e-05	0.000503	CcSEcCtD
Duloxetine—Back pain—Gabapentin—migraine	2.54e-05	0.000501	CcSEcCtD
Duloxetine—Hepatitis—Topiramate—migraine	2.53e-05	0.0005	CcSEcCtD
Duloxetine—Haemorrhage—Topiramate—migraine	2.53e-05	0.0005	CcSEcCtD
Duloxetine—Nervous system disorder—Valproic Acid—migraine	2.53e-05	0.0005	CcSEcCtD
Duloxetine—Vertigo—Timolol—migraine	2.53e-05	0.0005	CcSEcCtD
Duloxetine—Thrombocytopenia—Valproic Acid—migraine	2.53e-05	0.000499	CcSEcCtD
Duloxetine—Syncope—Timolol—migraine	2.52e-05	0.000499	CcSEcCtD
Duloxetine—Hallucination—Topiramate—migraine	2.52e-05	0.000498	CcSEcCtD
Duloxetine—Hypoaesthesia—Topiramate—migraine	2.52e-05	0.000498	CcSEcCtD
Duloxetine—Muscle spasms—Gabapentin—migraine	2.52e-05	0.000498	CcSEcCtD
Duloxetine—Tachycardia—Valproic Acid—migraine	2.52e-05	0.000497	CcSEcCtD
Duloxetine—Vomiting—Propranolol—migraine	2.52e-05	0.000497	CcSEcCtD
Duloxetine—Pharyngitis—Topiramate—migraine	2.51e-05	0.000497	CcSEcCtD
Duloxetine—HTR2A—G alpha (q) signalling events—EDNRA—migraine	2.51e-05	0.000913	CbGpPWpGaD
Duloxetine—Skin disorder—Valproic Acid—migraine	2.51e-05	0.000495	CcSEcCtD
Duloxetine—Urinary tract disorder—Topiramate—migraine	2.5e-05	0.000494	CcSEcCtD
Duloxetine—Oedema peripheral—Topiramate—migraine	2.5e-05	0.000493	CcSEcCtD
Duloxetine—Hyperhidrosis—Valproic Acid—migraine	2.49e-05	0.000493	CcSEcCtD
Duloxetine—Rash—Propranolol—migraine	2.49e-05	0.000493	CcSEcCtD
Duloxetine—Dermatitis—Propranolol—migraine	2.49e-05	0.000492	CcSEcCtD
Duloxetine—Diarrhoea—Verapamil—migraine	2.49e-05	0.000492	CcSEcCtD
Duloxetine—Connective tissue disorder—Topiramate—migraine	2.49e-05	0.000492	CcSEcCtD
Duloxetine—Palpitations—Timolol—migraine	2.49e-05	0.000491	CcSEcCtD
Duloxetine—Urethral disorder—Topiramate—migraine	2.48e-05	0.00049	CcSEcCtD
Duloxetine—NPY1R—Signaling by GPCR—HTR7—migraine	2.48e-05	0.000902	CbGpPWpGaD
Duloxetine—Loss of consciousness—Timolol—migraine	2.47e-05	0.000489	CcSEcCtD
Duloxetine—HTR2C—GPCR ligand binding—HTR2B—migraine	2.47e-05	0.0009	CbGpPWpGaD
Duloxetine—Vision blurred—Gabapentin—migraine	2.47e-05	0.000488	CcSEcCtD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	2.47e-05	0.000899	CbGpPWpGaD
Duloxetine—Anorexia—Valproic Acid—migraine	2.46e-05	0.000486	CcSEcCtD
Duloxetine—Cough—Timolol—migraine	2.46e-05	0.000485	CcSEcCtD
Duloxetine—Tremor—Gabapentin—migraine	2.46e-05	0.000485	CcSEcCtD
Duloxetine—Visual impairment—Topiramate—migraine	2.44e-05	0.000482	CcSEcCtD
Duloxetine—Ill-defined disorder—Gabapentin—migraine	2.43e-05	0.00048	CcSEcCtD
Duloxetine—Hypertension—Timolol—migraine	2.43e-05	0.00048	CcSEcCtD
Duloxetine—NPY1R—Signaling Pathways—LRP1—migraine	2.43e-05	0.000884	CbGpPWpGaD
Duloxetine—Anaemia—Gabapentin—migraine	2.42e-05	0.000479	CcSEcCtD
Duloxetine—Agitation—Gabapentin—migraine	2.41e-05	0.000476	CcSEcCtD
Duloxetine—Dizziness—Verapamil—migraine	2.41e-05	0.000475	CcSEcCtD
Duloxetine—Arthralgia—Timolol—migraine	2.4e-05	0.000473	CcSEcCtD
Duloxetine—Chest pain—Timolol—migraine	2.4e-05	0.000473	CcSEcCtD
Duloxetine—Myalgia—Timolol—migraine	2.4e-05	0.000473	CcSEcCtD
Duloxetine—Erythema multiforme—Topiramate—migraine	2.39e-05	0.000473	CcSEcCtD
Duloxetine—Angioedema—Gabapentin—migraine	2.39e-05	0.000473	CcSEcCtD
Duloxetine—Anxiety—Timolol—migraine	2.39e-05	0.000472	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	2.38e-05	0.00047	CcSEcCtD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	2.38e-05	0.000865	CbGpPWpGaD
Duloxetine—Discomfort—Timolol—migraine	2.37e-05	0.000468	CcSEcCtD
Duloxetine—Eye disorder—Topiramate—migraine	2.37e-05	0.000468	CcSEcCtD
Duloxetine—Malaise—Gabapentin—migraine	2.36e-05	0.000467	CcSEcCtD
Duloxetine—Tinnitus—Topiramate—migraine	2.36e-05	0.000467	CcSEcCtD
Duloxetine—Vertigo—Gabapentin—migraine	2.35e-05	0.000465	CcSEcCtD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	2.35e-05	0.000856	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	2.35e-05	0.000856	CbGpPWpGaD
Duloxetine—Musculoskeletal discomfort—Valproic Acid—migraine	2.35e-05	0.000464	CcSEcCtD
Duloxetine—Cardiac disorder—Topiramate—migraine	2.35e-05	0.000464	CcSEcCtD
Duloxetine—Flushing—Topiramate—migraine	2.35e-05	0.000464	CcSEcCtD
Duloxetine—Syncope—Gabapentin—migraine	2.35e-05	0.000464	CcSEcCtD
Duloxetine—Nausea—Propranolol—migraine	2.35e-05	0.000464	CcSEcCtD
Duloxetine—Leukopenia—Gabapentin—migraine	2.35e-05	0.000463	CcSEcCtD
Duloxetine—Dry mouth—Timolol—migraine	2.34e-05	0.000463	CcSEcCtD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	2.34e-05	0.000852	CbGpPWpGaD
Duloxetine—Insomnia—Valproic Acid—migraine	2.33e-05	0.000461	CcSEcCtD
Duloxetine—Paraesthesia—Valproic Acid—migraine	2.32e-05	0.000458	CcSEcCtD
Duloxetine—Palpitations—Gabapentin—migraine	2.32e-05	0.000458	CcSEcCtD
Duloxetine—Confusional state—Timolol—migraine	2.32e-05	0.000458	CcSEcCtD
Duloxetine—Vomiting—Verapamil—migraine	2.31e-05	0.000457	CcSEcCtD
Duloxetine—HTR2A—GPCR ligand binding—HTR1D—migraine	2.31e-05	0.000841	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	2.31e-05	0.00084	CbGpPWpGaD
Duloxetine—Loss of consciousness—Gabapentin—migraine	2.3e-05	0.000455	CcSEcCtD
Duloxetine—Angiopathy—Topiramate—migraine	2.3e-05	0.000454	CcSEcCtD
Duloxetine—Anaphylactic shock—Timolol—migraine	2.3e-05	0.000454	CcSEcCtD
Duloxetine—Oedema—Timolol—migraine	2.3e-05	0.000454	CcSEcCtD
Duloxetine—Rash—Verapamil—migraine	2.29e-05	0.000453	CcSEcCtD
Duloxetine—Somnolence—Valproic Acid—migraine	2.29e-05	0.000453	CcSEcCtD
Duloxetine—Dermatitis—Verapamil—migraine	2.29e-05	0.000453	CcSEcCtD
Duloxetine—Immune system disorder—Topiramate—migraine	2.29e-05	0.000452	CcSEcCtD
Duloxetine—Cough—Gabapentin—migraine	2.29e-05	0.000452	CcSEcCtD
Duloxetine—Mediastinal disorder—Topiramate—migraine	2.28e-05	0.000451	CcSEcCtD
Duloxetine—Infection—Timolol—migraine	2.28e-05	0.000451	CcSEcCtD
Duloxetine—Headache—Verapamil—migraine	2.28e-05	0.00045	CcSEcCtD
Duloxetine—Chills—Topiramate—migraine	2.27e-05	0.000449	CcSEcCtD
Duloxetine—Dyspepsia—Valproic Acid—migraine	2.27e-05	0.000449	CcSEcCtD
Duloxetine—Convulsion—Gabapentin—migraine	2.27e-05	0.000449	CcSEcCtD
Duloxetine—Hypertension—Gabapentin—migraine	2.26e-05	0.000447	CcSEcCtD
Duloxetine—Shock—Timolol—migraine	2.26e-05	0.000446	CcSEcCtD
Duloxetine—Nervous system disorder—Timolol—migraine	2.25e-05	0.000445	CcSEcCtD
Duloxetine—Decreased appetite—Valproic Acid—migraine	2.24e-05	0.000443	CcSEcCtD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	2.24e-05	0.000817	CbGpPWpGaD
Duloxetine—Alopecia—Topiramate—migraine	2.24e-05	0.000442	CcSEcCtD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	2.23e-05	0.000813	CbGpPWpGaD
Duloxetine—Myalgia—Gabapentin—migraine	2.23e-05	0.000441	CcSEcCtD
Duloxetine—Chest pain—Gabapentin—migraine	2.23e-05	0.000441	CcSEcCtD
Duloxetine—Arthralgia—Gabapentin—migraine	2.23e-05	0.000441	CcSEcCtD
Duloxetine—Skin disorder—Timolol—migraine	2.23e-05	0.000441	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Valproic Acid—migraine	2.23e-05	0.00044	CcSEcCtD
Duloxetine—Fatigue—Valproic Acid—migraine	2.22e-05	0.000439	CcSEcCtD
Duloxetine—Anxiety—Gabapentin—migraine	2.22e-05	0.000439	CcSEcCtD
Duloxetine—Hyperhidrosis—Timolol—migraine	2.22e-05	0.000439	CcSEcCtD
Duloxetine—Mental disorder—Topiramate—migraine	2.22e-05	0.000438	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	2.22e-05	0.000438	CcSEcCtD
Duloxetine—Pain—Valproic Acid—migraine	2.21e-05	0.000436	CcSEcCtD
Duloxetine—Constipation—Valproic Acid—migraine	2.21e-05	0.000436	CcSEcCtD
Duloxetine—Erythema—Topiramate—migraine	2.2e-05	0.000436	CcSEcCtD
Duloxetine—Malnutrition—Topiramate—migraine	2.2e-05	0.000436	CcSEcCtD
Duloxetine—Discomfort—Gabapentin—migraine	2.2e-05	0.000436	CcSEcCtD
Duloxetine—Anorexia—Timolol—migraine	2.19e-05	0.000433	CcSEcCtD
Duloxetine—HTR6—GPCR ligand binding—HTR1B—migraine	2.19e-05	0.000797	CbGpPWpGaD
Duloxetine—Dry mouth—Gabapentin—migraine	2.18e-05	0.000431	CcSEcCtD
Duloxetine—Flatulence—Topiramate—migraine	2.17e-05	0.000429	CcSEcCtD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	2.16e-05	0.000789	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—BDNF—migraine	2.16e-05	0.000788	CbGpPWpGaD
Duloxetine—Tension—Topiramate—migraine	2.16e-05	0.000427	CcSEcCtD
Duloxetine—Nausea—Verapamil—migraine	2.16e-05	0.000427	CcSEcCtD
Duloxetine—Dysgeusia—Topiramate—migraine	2.16e-05	0.000427	CcSEcCtD
Duloxetine—Confusional state—Gabapentin—migraine	2.16e-05	0.000426	CcSEcCtD
Duloxetine—HTR2A—GPCR ligand binding—HTR2B—migraine	2.15e-05	0.000782	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	2.14e-05	0.000781	CbGpPWpGaD
Duloxetine—Nervousness—Topiramate—migraine	2.14e-05	0.000423	CcSEcCtD
Duloxetine—Oedema—Gabapentin—migraine	2.14e-05	0.000423	CcSEcCtD
Duloxetine—Anaphylactic shock—Gabapentin—migraine	2.14e-05	0.000423	CcSEcCtD
Duloxetine—Back pain—Topiramate—migraine	2.13e-05	0.000421	CcSEcCtD
Duloxetine—Feeling abnormal—Valproic Acid—migraine	2.13e-05	0.00042	CcSEcCtD
Duloxetine—Infection—Gabapentin—migraine	2.12e-05	0.00042	CcSEcCtD
Duloxetine—Muscle spasms—Topiramate—migraine	2.12e-05	0.000419	CcSEcCtD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	2.11e-05	0.00077	CbGpPWpGaD
Duloxetine—Gastrointestinal pain—Valproic Acid—migraine	2.11e-05	0.000417	CcSEcCtD
Duloxetine—HTR6—GPCR ligand binding—HTR1A—migraine	2.11e-05	0.000767	CbGpPWpGaD
Duloxetine—Shock—Gabapentin—migraine	2.1e-05	0.000416	CcSEcCtD
Duloxetine—Nervous system disorder—Gabapentin—migraine	2.1e-05	0.000414	CcSEcCtD
Duloxetine—Thrombocytopenia—Gabapentin—migraine	2.09e-05	0.000414	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Timolol—migraine	2.09e-05	0.000413	CcSEcCtD
Duloxetine—Tachycardia—Gabapentin—migraine	2.09e-05	0.000412	CcSEcCtD
Duloxetine—Vision blurred—Topiramate—migraine	2.08e-05	0.000411	CcSEcCtD
Duloxetine—Skin disorder—Gabapentin—migraine	2.08e-05	0.00041	CcSEcCtD
Duloxetine—Insomnia—Timolol—migraine	2.08e-05	0.00041	CcSEcCtD
Duloxetine—HTR6—GPCR ligand binding—TAC1—migraine	2.07e-05	0.000755	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—NPS—migraine	2.07e-05	0.000755	CbGpPWpGaD
Duloxetine—Hyperhidrosis—Gabapentin—migraine	2.07e-05	0.000408	CcSEcCtD
Duloxetine—HTR2C—GPCR downstream signaling—RAMP1—migraine	2.07e-05	0.000753	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CALCRL—migraine	2.07e-05	0.000753	CbGpPWpGaD
Duloxetine—Tremor—Topiramate—migraine	2.07e-05	0.000408	CcSEcCtD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	2.06e-05	0.000752	CbGpPWpGaD
Duloxetine—Paraesthesia—Timolol—migraine	2.06e-05	0.000407	CcSEcCtD
Duloxetine—Urticaria—Valproic Acid—migraine	2.05e-05	0.000405	CcSEcCtD
Duloxetine—Ill-defined disorder—Topiramate—migraine	2.05e-05	0.000404	CcSEcCtD
Duloxetine—Somnolence—Timolol—migraine	2.04e-05	0.000403	CcSEcCtD
Duloxetine—HTR6—GPCR downstream signaling—HTR1D—migraine	2.04e-05	0.000743	CbGpPWpGaD
Duloxetine—Abdominal pain—Valproic Acid—migraine	2.04e-05	0.000403	CcSEcCtD
Duloxetine—Body temperature increased—Valproic Acid—migraine	2.04e-05	0.000403	CcSEcCtD
Duloxetine—Anorexia—Gabapentin—migraine	2.04e-05	0.000403	CcSEcCtD
Duloxetine—Anaemia—Topiramate—migraine	2.04e-05	0.000403	CcSEcCtD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	2.04e-05	0.000741	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—HTR2C—migraine	2.03e-05	0.000741	CbGpPWpGaD
Duloxetine—Agitation—Topiramate—migraine	2.03e-05	0.0004	CcSEcCtD
Duloxetine—Dyspepsia—Timolol—migraine	2.02e-05	0.000399	CcSEcCtD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR7—migraine	2.01e-05	0.000732	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	2e-05	0.00073	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	2e-05	0.00073	CbGpPWpGaD
Duloxetine—Decreased appetite—Timolol—migraine	2e-05	0.000394	CcSEcCtD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	1.99e-05	0.000726	CbGpPWpGaD
Duloxetine—Malaise—Topiramate—migraine	1.99e-05	0.000393	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Timolol—migraine	1.98e-05	0.000392	CcSEcCtD
Duloxetine—Vertigo—Topiramate—migraine	1.98e-05	0.000391	CcSEcCtD
Duloxetine—Fatigue—Timolol—migraine	1.98e-05	0.000391	CcSEcCtD
Duloxetine—HTR6—GPCR ligand binding—EDNRA—migraine	1.98e-05	0.00072	CbGpPWpGaD
Duloxetine—Syncope—Topiramate—migraine	1.98e-05	0.000391	CcSEcCtD
Duloxetine—Leukopenia—Topiramate—migraine	1.97e-05	0.00039	CcSEcCtD
Duloxetine—Pain—Timolol—migraine	1.96e-05	0.000388	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Gabapentin—migraine	1.95e-05	0.000385	CcSEcCtD
Duloxetine—Palpitations—Topiramate—migraine	1.95e-05	0.000385	CcSEcCtD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	1.94e-05	0.000706	CbGpPWpGaD
Duloxetine—Loss of consciousness—Topiramate—migraine	1.94e-05	0.000383	CcSEcCtD
Duloxetine—Insomnia—Gabapentin—migraine	1.93e-05	0.000382	CcSEcCtD
Duloxetine—Cough—Topiramate—migraine	1.92e-05	0.00038	CcSEcCtD
Duloxetine—Paraesthesia—Gabapentin—migraine	1.92e-05	0.000379	CcSEcCtD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	1.91e-05	0.000697	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	1.91e-05	0.000696	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—HTR2A—migraine	1.91e-05	0.000696	CbGpPWpGaD
Duloxetine—Convulsion—Topiramate—migraine	1.91e-05	0.000377	CcSEcCtD
Duloxetine—HTR6—GPCR ligand binding—CALCA—migraine	1.9e-05	0.000693	CbGpPWpGaD
Duloxetine—Hypertension—Topiramate—migraine	1.9e-05	0.000376	CcSEcCtD
Duloxetine—Somnolence—Gabapentin—migraine	1.9e-05	0.000376	CcSEcCtD
Duloxetine—Hypersensitivity—Valproic Acid—migraine	1.9e-05	0.000376	CcSEcCtD
Duloxetine—HTR6—GPCR downstream signaling—HTR2B—migraine	1.9e-05	0.000691	CbGpPWpGaD
Duloxetine—Feeling abnormal—Timolol—migraine	1.89e-05	0.000374	CcSEcCtD
Duloxetine—Dyspepsia—Gabapentin—migraine	1.88e-05	0.000372	CcSEcCtD
Duloxetine—Gastrointestinal pain—Timolol—migraine	1.88e-05	0.000371	CcSEcCtD
Duloxetine—HTR2C—Signaling by GPCR—RAMP1—migraine	1.88e-05	0.000684	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CALCRL—migraine	1.88e-05	0.000684	CbGpPWpGaD
Duloxetine—Myalgia—Topiramate—migraine	1.88e-05	0.000371	CcSEcCtD
Duloxetine—Chest pain—Topiramate—migraine	1.88e-05	0.000371	CcSEcCtD
Duloxetine—Arthralgia—Topiramate—migraine	1.88e-05	0.000371	CcSEcCtD
Duloxetine—Anxiety—Topiramate—migraine	1.87e-05	0.00037	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	1.86e-05	0.000368	CcSEcCtD
Duloxetine—NPY1R—Signaling Pathways—NOTCH4—migraine	1.86e-05	0.000679	CbGpPWpGaD
Duloxetine—Decreased appetite—Gabapentin—migraine	1.86e-05	0.000367	CcSEcCtD
Duloxetine—Discomfort—Topiramate—migraine	1.85e-05	0.000366	CcSEcCtD
Duloxetine—HTR6—Signaling by GPCR—HTR1D—migraine	1.85e-05	0.000675	CbGpPWpGaD
Duloxetine—Asthenia—Valproic Acid—migraine	1.85e-05	0.000366	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Gabapentin—migraine	1.85e-05	0.000365	CcSEcCtD
Duloxetine—Fatigue—Gabapentin—migraine	1.84e-05	0.000364	CcSEcCtD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	1.84e-05	0.000669	CbGpPWpGaD
Duloxetine—Dry mouth—Topiramate—migraine	1.84e-05	0.000363	CcSEcCtD
Duloxetine—Constipation—Gabapentin—migraine	1.83e-05	0.000361	CcSEcCtD
Duloxetine—Pain—Gabapentin—migraine	1.83e-05	0.000361	CcSEcCtD
Duloxetine—Pruritus—Valproic Acid—migraine	1.83e-05	0.000361	CcSEcCtD
Duloxetine—Urticaria—Timolol—migraine	1.82e-05	0.00036	CcSEcCtD
Duloxetine—HTR2C—G alpha (q) signalling events—HTR2A—migraine	1.82e-05	0.000663	CbGpPWpGaD
Duloxetine—Abdominal pain—Timolol—migraine	1.82e-05	0.000359	CcSEcCtD
Duloxetine—Body temperature increased—Timolol—migraine	1.82e-05	0.000359	CcSEcCtD
Duloxetine—Confusional state—Topiramate—migraine	1.81e-05	0.000358	CcSEcCtD
Duloxetine—Oedema—Topiramate—migraine	1.8e-05	0.000355	CcSEcCtD
Duloxetine—NPY1R—Signaling Pathways—HTR1B—migraine	1.8e-05	0.000655	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CALCRL—migraine	1.8e-05	0.000654	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—RAMP1—migraine	1.8e-05	0.000654	CbGpPWpGaD
Duloxetine—Infection—Topiramate—migraine	1.79e-05	0.000353	CcSEcCtD
Duloxetine—HTR6—GPCR ligand binding—HTR7—migraine	1.78e-05	0.000649	CbGpPWpGaD
Duloxetine—Shock—Topiramate—migraine	1.77e-05	0.00035	CcSEcCtD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	1.77e-05	0.000644	CbGpPWpGaD
Duloxetine—Diarrhoea—Valproic Acid—migraine	1.77e-05	0.000349	CcSEcCtD
Duloxetine—Nervous system disorder—Topiramate—migraine	1.76e-05	0.000349	CcSEcCtD
Duloxetine—Feeling abnormal—Gabapentin—migraine	1.76e-05	0.000348	CcSEcCtD
Duloxetine—Thrombocytopenia—Topiramate—migraine	1.76e-05	0.000348	CcSEcCtD
Duloxetine—Tachycardia—Topiramate—migraine	1.76e-05	0.000347	CcSEcCtD
Duloxetine—Gastrointestinal pain—Gabapentin—migraine	1.75e-05	0.000346	CcSEcCtD
Duloxetine—Skin disorder—Topiramate—migraine	1.75e-05	0.000345	CcSEcCtD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	1.75e-05	0.000636	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	1.74e-05	0.000634	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	1.74e-05	0.000634	CbGpPWpGaD
Duloxetine—Hyperhidrosis—Topiramate—migraine	1.74e-05	0.000344	CcSEcCtD
Duloxetine—NPY1R—Signaling by GPCR—HTR2A—migraine	1.74e-05	0.000632	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—HTR1A—migraine	1.73e-05	0.00063	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—HTR2B—migraine	1.72e-05	0.000627	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	1.72e-05	0.000627	CbGpPWpGaD
Duloxetine—Anorexia—Topiramate—migraine	1.72e-05	0.000339	CcSEcCtD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	1.71e-05	0.000622	CbGpPWpGaD
Duloxetine—Dizziness—Valproic Acid—migraine	1.71e-05	0.000337	CcSEcCtD
Duloxetine—NPY1R—Signaling Pathways—NPS—migraine	1.7e-05	0.000621	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—PGR—migraine	1.7e-05	0.000621	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—TAC1—migraine	1.7e-05	0.000621	CbGpPWpGaD
Duloxetine—Urticaria—Gabapentin—migraine	1.7e-05	0.000336	CcSEcCtD
Duloxetine—Hypersensitivity—Timolol—migraine	1.69e-05	0.000334	CcSEcCtD
Duloxetine—Abdominal pain—Gabapentin—migraine	1.69e-05	0.000334	CcSEcCtD
Duloxetine—Body temperature increased—Gabapentin—migraine	1.69e-05	0.000334	CcSEcCtD
Duloxetine—NPY1R—Signaling Pathways—HTR2C—migraine	1.67e-05	0.000609	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	1.66e-05	0.000605	CbGpPWpGaD
Duloxetine—Asthenia—Timolol—migraine	1.65e-05	0.000326	CcSEcCtD
Duloxetine—Vomiting—Valproic Acid—migraine	1.64e-05	0.000324	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Topiramate—migraine	1.64e-05	0.000324	CcSEcCtD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	1.64e-05	0.000597	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—RAMP1—migraine	1.63e-05	0.000594	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CALCRL—migraine	1.63e-05	0.000594	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	1.63e-05	0.000593	CbGpPWpGaD
Duloxetine—Insomnia—Topiramate—migraine	1.63e-05	0.000322	CcSEcCtD
Duloxetine—Rash—Valproic Acid—migraine	1.63e-05	0.000321	CcSEcCtD
Duloxetine—Dermatitis—Valproic Acid—migraine	1.63e-05	0.000321	CcSEcCtD
Duloxetine—NPY1R—Signaling Pathways—EDNRA—migraine	1.63e-05	0.000592	CbGpPWpGaD
Duloxetine—Pruritus—Timolol—migraine	1.63e-05	0.000321	CcSEcCtD
Duloxetine—Headache—Valproic Acid—migraine	1.62e-05	0.000319	CcSEcCtD
Duloxetine—Paraesthesia—Topiramate—migraine	1.62e-05	0.000319	CcSEcCtD
Duloxetine—HTR2C—GPCR ligand binding—HTR1B—migraine	1.61e-05	0.000587	CbGpPWpGaD
Duloxetine—Somnolence—Topiramate—migraine	1.6e-05	0.000316	CcSEcCtD
Duloxetine—Dyspepsia—Topiramate—migraine	1.58e-05	0.000313	CcSEcCtD
Duloxetine—NPY1R—Signaling Pathways—NOTCH3—migraine	1.58e-05	0.000577	CbGpPWpGaD
Duloxetine—Hypersensitivity—Gabapentin—migraine	1.58e-05	0.000311	CcSEcCtD
Duloxetine—Diarrhoea—Timolol—migraine	1.57e-05	0.00031	CcSEcCtD
Duloxetine—NPY1R—Signaling Pathways—CALCA—migraine	1.56e-05	0.00057	CbGpPWpGaD
Duloxetine—Decreased appetite—Topiramate—migraine	1.56e-05	0.000309	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Topiramate—migraine	1.55e-05	0.000307	CcSEcCtD
Duloxetine—Fatigue—Topiramate—migraine	1.55e-05	0.000306	CcSEcCtD
Duloxetine—HTR2C—GPCR ligand binding—HTR1A—migraine	1.55e-05	0.000565	CbGpPWpGaD
Duloxetine—Pain—Topiramate—migraine	1.54e-05	0.000304	CcSEcCtD
Duloxetine—Constipation—Topiramate—migraine	1.54e-05	0.000304	CcSEcCtD
Duloxetine—Asthenia—Gabapentin—migraine	1.53e-05	0.000303	CcSEcCtD
Duloxetine—Nausea—Valproic Acid—migraine	1.53e-05	0.000303	CcSEcCtD
Duloxetine—HTR2C—GPCR ligand binding—NPS—migraine	1.53e-05	0.000556	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—TAC1—migraine	1.53e-05	0.000556	CbGpPWpGaD
Duloxetine—Dizziness—Timolol—migraine	1.52e-05	0.0003	CcSEcCtD
Duloxetine—Pruritus—Gabapentin—migraine	1.51e-05	0.000299	CcSEcCtD
Duloxetine—HTR6—Signaling Pathways—CALCRL—migraine	1.51e-05	0.000549	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—RAMP1—migraine	1.51e-05	0.000549	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—HTR1D—migraine	1.5e-05	0.000547	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	1.5e-05	0.000545	CbGpPWpGaD
Duloxetine—Feeling abnormal—Topiramate—migraine	1.48e-05	0.000293	CcSEcCtD
Duloxetine—Gastrointestinal pain—Topiramate—migraine	1.47e-05	0.000291	CcSEcCtD
Duloxetine—Diarrhoea—Gabapentin—migraine	1.46e-05	0.000289	CcSEcCtD
Duloxetine—NPY1R—Signaling Pathways—HTR7—migraine	1.46e-05	0.000533	CbGpPWpGaD
Duloxetine—Vomiting—Timolol—migraine	1.46e-05	0.000289	CcSEcCtD
Duloxetine—HTR2C—GPCR ligand binding—EDNRA—migraine	1.46e-05	0.00053	CbGpPWpGaD
Duloxetine—Rash—Timolol—migraine	1.45e-05	0.000286	CcSEcCtD
Duloxetine—Dermatitis—Timolol—migraine	1.45e-05	0.000286	CcSEcCtD
Duloxetine—Headache—Timolol—migraine	1.44e-05	0.000284	CcSEcCtD
Duloxetine—Urticaria—Topiramate—migraine	1.43e-05	0.000282	CcSEcCtD
Duloxetine—Body temperature increased—Topiramate—migraine	1.42e-05	0.000281	CcSEcCtD
Duloxetine—Abdominal pain—Topiramate—migraine	1.42e-05	0.000281	CcSEcCtD
Duloxetine—Dizziness—Gabapentin—migraine	1.41e-05	0.000279	CcSEcCtD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	1.41e-05	0.000513	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CALCA—migraine	1.4e-05	0.000511	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—HTR1B—migraine	1.4e-05	0.000509	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—HTR2B—migraine	1.4e-05	0.000509	CbGpPWpGaD
Duloxetine—Nausea—Timolol—migraine	1.36e-05	0.00027	CcSEcCtD
Duloxetine—HTR2C—Signaling by GPCR—HTR1D—migraine	1.36e-05	0.000497	CbGpPWpGaD
Duloxetine—Vomiting—Gabapentin—migraine	1.36e-05	0.000269	CcSEcCtD
Duloxetine—Rash—Gabapentin—migraine	1.35e-05	0.000266	CcSEcCtD
Duloxetine—Dermatitis—Gabapentin—migraine	1.35e-05	0.000266	CcSEcCtD
Duloxetine—HTR2A—GPCR ligand binding—HTR1A—migraine	1.35e-05	0.00049	CbGpPWpGaD
Duloxetine—Headache—Gabapentin—migraine	1.34e-05	0.000265	CcSEcCtD
Duloxetine—Hypersensitivity—Topiramate—migraine	1.33e-05	0.000262	CcSEcCtD
Duloxetine—HTR2A—GPCR ligand binding—TAC1—migraine	1.33e-05	0.000483	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—NPS—migraine	1.33e-05	0.000483	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—HTR7—migraine	1.31e-05	0.000478	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—TNF—migraine	1.31e-05	0.000476	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—HTR1D—migraine	1.3e-05	0.000475	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—HTR2C—migraine	1.3e-05	0.000474	CbGpPWpGaD
Duloxetine—Asthenia—Topiramate—migraine	1.29e-05	0.000255	CcSEcCtD
Duloxetine—Pruritus—Topiramate—migraine	1.27e-05	0.000252	CcSEcCtD
Duloxetine—Nausea—Gabapentin—migraine	1.27e-05	0.000251	CcSEcCtD
Duloxetine—HTR2C—Signaling by GPCR—HTR2B—migraine	1.27e-05	0.000462	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—EDNRA—migraine	1.26e-05	0.000461	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—TGFBR2—migraine	1.26e-05	0.000459	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—HTR2A—migraine	1.25e-05	0.000454	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—HTR1B—migraine	1.24e-05	0.00045	CbGpPWpGaD
Duloxetine—Diarrhoea—Topiramate—migraine	1.23e-05	0.000243	CcSEcCtD
Duloxetine—HTR2A—GPCR ligand binding—CALCA—migraine	1.22e-05	0.000443	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—HTR2B—migraine	1.21e-05	0.000442	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	1.21e-05	0.000439	CbGpPWpGaD
Duloxetine—Dizziness—Topiramate—migraine	1.19e-05	0.000235	CcSEcCtD
Duloxetine—HTR6—GPCR downstream signaling—HTR1A—migraine	1.19e-05	0.000433	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HTR1D—migraine	1.18e-05	0.000431	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—NPS—migraine	1.17e-05	0.000427	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—TAC1—migraine	1.17e-05	0.000427	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—HTR2C—migraine	1.15e-05	0.000418	CbGpPWpGaD
Duloxetine—Vomiting—Topiramate—migraine	1.14e-05	0.000226	CcSEcCtD
Duloxetine—HTR2A—GPCR ligand binding—HTR7—migraine	1.14e-05	0.000415	CbGpPWpGaD
Duloxetine—Rash—Topiramate—migraine	1.13e-05	0.000224	CcSEcCtD
Duloxetine—Dermatitis—Topiramate—migraine	1.13e-05	0.000224	CcSEcCtD
Duloxetine—Headache—Topiramate—migraine	1.13e-05	0.000223	CcSEcCtD
Duloxetine—HTR6—Signaling by GPCR—HTR1B—migraine	1.12e-05	0.000409	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—EDNRA—migraine	1.12e-05	0.000407	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CALCRL—migraine	1.11e-05	0.000404	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—RAMP1—migraine	1.11e-05	0.000404	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HTR2B—migraine	1.1e-05	0.000401	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR1D—migraine	1.09e-05	0.000399	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—HTR1A—migraine	1.08e-05	0.000393	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CALCA—migraine	1.08e-05	0.000392	CbGpPWpGaD
Duloxetine—Nausea—Topiramate—migraine	1.07e-05	0.000211	CcSEcCtD
Duloxetine—HTR6—Signaling by GPCR—TAC1—migraine	1.06e-05	0.000388	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—NPS—migraine	1.06e-05	0.000388	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	1.05e-05	0.000382	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	1.05e-05	0.000382	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—HTR2C—migraine	1.04e-05	0.00038	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—HTR2A—migraine	1.02e-05	0.000373	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR2B—migraine	1.02e-05	0.000371	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—EDNRA—migraine	1.01e-05	0.00037	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—HTR7—migraine	1.01e-05	0.000367	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CALCA—migraine	9.77e-06	0.000356	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—RAMP1—migraine	9.63e-06	0.000351	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CALCRL—migraine	9.63e-06	0.000351	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—HTR2A—migraine	9.18e-06	0.000335	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—HTR7—migraine	9.14e-06	0.000333	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—HTR1B—migraine	9.1e-06	0.000331	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—ESR1—migraine	9.1e-06	0.000331	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—LRP1—migraine	8.96e-06	0.000326	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—HTR1A—migraine	8.76e-06	0.000319	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—TAC1—migraine	8.63e-06	0.000314	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—NPS—migraine	8.63e-06	0.000314	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—HTR1B—migraine	8.26e-06	0.000301	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—EDNRA—migraine	8.23e-06	0.0003	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR1D—migraine	8.06e-06	0.000294	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—HTR1A—migraine	7.96e-06	0.00029	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CALCA—migraine	7.92e-06	0.000289	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—HTR1B—migraine	7.9e-06	0.000288	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—TNF—migraine	7.86e-06	0.000286	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—TAC1—migraine	7.83e-06	0.000285	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—NPS—migraine	7.83e-06	0.000285	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—HTR1A—migraine	7.61e-06	0.000277	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—NPS—migraine	7.49e-06	0.000273	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—TAC1—migraine	7.49e-06	0.000273	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR2B—migraine	7.49e-06	0.000273	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—EDNRA—migraine	7.47e-06	0.000272	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—HTR7—migraine	7.41e-06	0.00027	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—HTR2C—migraine	7.35e-06	0.000268	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CALCA—migraine	7.19e-06	0.000262	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HTR1B—migraine	7.18e-06	0.000261	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—EDNRA—migraine	7.15e-06	0.00026	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—HTR2A—migraine	7.05e-06	0.000257	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HTR1D—migraine	7e-06	0.000255	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HTR1A—migraine	6.91e-06	0.000252	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CALCA—migraine	6.88e-06	0.000251	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NOTCH4—migraine	6.87e-06	0.00025	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—TAC1—migraine	6.8e-06	0.000248	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—NPS—migraine	6.8e-06	0.000248	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—HTR7—migraine	6.73e-06	0.000245	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HTR2C—migraine	6.67e-06	0.000243	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR1B—migraine	6.63e-06	0.000241	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—LRP1—migraine	6.6e-06	0.00024	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HTR2B—migraine	6.51e-06	0.000237	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—EDNRA—migraine	6.49e-06	0.000236	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—HTR7—migraine	6.44e-06	0.000234	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—HTR2A—migraine	6.4e-06	0.000233	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR1A—migraine	6.38e-06	0.000232	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NPS—migraine	6.28e-06	0.000229	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—PGR—migraine	6.28e-06	0.000229	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TAC1—migraine	6.28e-06	0.000229	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CALCA—migraine	6.25e-06	0.000228	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR2C—migraine	6.16e-06	0.000224	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—EDNRA—migraine	6e-06	0.000218	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HTR7—migraine	5.84e-06	0.000213	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NOTCH3—migraine	5.84e-06	0.000213	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CALCA—migraine	5.77e-06	0.00021	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—LRP1—migraine	5.73e-06	0.000209	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR7—migraine	5.4e-06	0.000197	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—HTR2A—migraine	5.19e-06	0.000189	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CACNA1A—migraine	5.17e-06	0.000188	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NOTCH4—migraine	5.06e-06	0.000184	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR1B—migraine	4.88e-06	0.000178	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—HTR2A—migraine	4.71e-06	0.000172	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR1A—migraine	4.7e-06	0.000171	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TGFBR2—migraine	4.65e-06	0.000169	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TAC1—migraine	4.63e-06	0.000169	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NPS—migraine	4.63e-06	0.000169	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PGR—migraine	4.63e-06	0.000169	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—EDNRA—migraine	4.42e-06	0.000161	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NOTCH4—migraine	4.39e-06	0.00016	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CACNA1A—migraine	4.38e-06	0.00016	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NOTCH3—migraine	4.3e-06	0.000157	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CALCA—migraine	4.25e-06	0.000155	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HTR1B—migraine	4.24e-06	0.000154	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HTR1A—migraine	4.08e-06	0.000149	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NPS—migraine	4.02e-06	0.000146	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TAC1—migraine	4.02e-06	0.000146	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PGR—migraine	4.02e-06	0.000146	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR7—migraine	3.98e-06	0.000145	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HTR2C—migraine	3.94e-06	0.000144	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—EDNRA—migraine	3.83e-06	0.00014	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR2A—migraine	3.78e-06	0.000138	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NOTCH3—migraine	3.74e-06	0.000136	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CALCA—migraine	3.69e-06	0.000134	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HTR7—migraine	3.45e-06	0.000126	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TGFBR2—migraine	3.42e-06	0.000125	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ESR1—migraine	3.36e-06	0.000122	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TGFBR2—migraine	2.97e-06	0.000108	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR2A—migraine	2.78e-06	0.000101	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ESR1—migraine	2.47e-06	9e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ESR1—migraine	2.15e-06	7.82e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—MTHFR—migraine	1.71e-06	6.24e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—MTHFR—migraine	1.45e-06	5.28e-05	CbGpPWpGaD
